Synageva BioPharma Corp (NASDAQ:GEVA)

98.69
Delayed Data
As of Mar 27
 +6.02 / +6.50%
Today’s Change
60.19
Today|||52-Week Range
122.88
+6.36%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Baker Bros Advisors Lp
Buy1/07/20151,000,000$94.19$94.2M-5.12%
Baker Bros Advisors Lp
Buy1/07/20151,000,000$94.19$94.2M-5.12%
Patel Sanj K
President & Chief Executive Officer
Sale12/17/201426,960$90.06$2.4M+2.76%
Boess Carsten
Chief Financial Officer & Senior Vice President
Sale10/30/201422,904$80.11$1.8M+23.27%
Goldberg Mark Alan
Sale6/11/201421,597$80.00$1.7M+22.02%
Boess Carsten
Chief Financial Officer & Senior Vice President
Sale2/17/201516,716$100.74$1.7M-0.18%
Boess Carsten
Chief Financial Officer & Senior Vice President
Sale2/17/201514,750$99.97$1.5M-0.18%
Patel Sanj K
President & Chief Executive Officer
Sale12/17/201413,536$87.55$1.2M+2.76%
Boess Carsten
Chief Financial Officer & Senior Vice President
Buy2/17/201529,062$40.74$1.2M-0.18%
Boess Carsten
Chief Financial Officer & Senior Vice President
Sale2/17/20158,989$98.85$888.6K-0.18%
Page of 9

To view my watchlist

Not a member yet?

Sign up now for a free account